Back to companies

Grifols SA: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Grifols SA (Grifols) is a pharmaceutical and chemical manufacturing company engaged on enhancing the health and well-being of patients worldwide. It is focused on research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. It produces plasma derived protein therapies for patients suffering with rare, chronic and life-threatening infections. Grifols offers biological materials for clinical trials, biotechnology research, manufacturing pharmaceutical and diagnostic products. Grifols provides transfusion medicine, hemostasis and immunoassay solutions for blood banks, clinical laboratories and transfusion centers. The company offers its products to hospitals, pharmacies and healthcare professionals. It offers products in the US, Canada, Europe, and Rest of the world. Grifols is headquartered in Barcelona, Spain.

Headquarters Spain

Address C/ Jesus Y Maria, 6, Barcelona, 08022


Telephone 34 935 710000

No of Employees 23,233

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange GRF (MCE)

Revenue (2021) $5.8B -7.6% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -70.4% (2021 vs 2020)

Market Cap* $12.3B

Net Profit Margin (2021) XXX -68.0% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

210+

Clinical Trials

Determine Grifols SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

120+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

100+

Catalyst Calendar

Proactively evaluate Grifols SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

80+

Pipeline Drugs

Identify which of Grifols SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

80+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Grifols SA’s relevant decision makers and contact details.

30+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

20+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

20+

Marketed Drugs

Understand Grifols SA’s commercialized product portfolio to stay one step ahead of the market.

16+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

8

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Bioscience: Albutein
Plasma Derivative Products Alphanate
Diagnostic: Anbinex
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Acquisitions/Mergers/Takeovers In April, the company announced the completion of the acquisition of 100% stake of Tiancheng (Germany) Pharmaceutical Holdings AG.
2022 Contracts/Agreements In March, the company partnered with Feeding America to help "box out hunger" by collecting nonperishable food and raising money for local member food banks across the country.
2022 Contracts/Agreements In February, the company entered into a global collaboration and licensing agreement with Endpoint Health for exclusive rights to develop and commercialize Antithrombin III (AT-III) in sepsis.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Grifols SA Takeda Pharmaceutical Co Ltd CSL Ltd Omnicell Inc Abeona Therapeutics Inc
Headquarters Spain Japan Australia United States of America United States of America
City Barcelona Chuo-Ku Melbourne Mountain View New York
State/Province - Tokyo Victoria California New York
No. of Employees 23,233 47,099 25,000 3,800 90
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Net Income Growth

Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Raimon Grifols Roura Co - Chief Executive Officer; Director Executive Board 2017 -
Victor Grifols Deu Director; Co - Chief Executive Officer Executive Board 2016 -
Alfredo Arroyo Guerra Chief Financial Officer Senior Management - -
Maria Teresa Rione Chief Communications Officer Senior Management - -
Albert Grifols Coma-Cros Chief Scientific Innovation Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer